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Abstracts / International Journal of Surgery 23 (2015) S15eS134 S19Aim: Review mortality, infections and CSF sampling in EVD patients.
Methods: Theatre shunt register and laboratory results were used to
collect data from August 2012 to b2014.
Results: 141 EVDs were inserted in 117 patients. The mortality rate within
2 months of operation was 36%. Mortality was highest in patients with
intra-ventricular haemorrhage (69%) and malignant tumours (67%). 258
CSF samples were taken for analysis costing £4,987.14. 38% of patients had
an intra-operative sample sent, none of which grew an infective organism
without pre-existing shunt or infection. The iatrogenic infection rate was
7% however 4 of these were potential contaminant organisms (coagulase-
negative staphylococcus), and a further 4 contaminants were not treated.
Neither the number of samples taken from EVDs, nor the CSF cell counts
were associated with infection.
Conclusion: We have demonstrated the high mortality associated with
patients requiring EVDs, knowledge of which has been incorporated into
our practise when counselling patients and families. We have also high-
lighted the lack of value of cell count intra-operative sampling in pre-
dicting infection. To improve efﬁciency our microbiologists are reviewing
use of routine cell counts, favouring culture only. We also recommend only
sampling patients with a high index of suspected infection to avoid over-
treating contaminants.
0562: OPPORTUNITY FOR CARDIOVASCULAR RISK FACTOR REDUCTION
IN AAA SURVEILLANCE PROGRAMS: A SYSTEMATIC REVIEW AND META-
ANALYSIS OF CARDIOVASCULAR MORTALITY IN PATIENTS WITH SMALL
AAA
M. Bath 1,*, V. Gokani 2, D. Sidloff 2, L. Jones 1, E. Choke 2, R. Sayers 2, M.
Bown 2. 1 Leicester Medical School, UK; 2University of Leicester, UK
Aim: Screening for abdominal aortic aneurysm (AAA) has dramatically
reduced the rate of AAA-rupture, yet cardiovascular mortality remains a
major cause of death in this patient group. A diagnosis of AAA is a powerful
marker of cardiovascular risk, yet only 12.4% of patients use statins. The
aim of this study was to assess the cardiovascular risk in patients with
small AAA.
Methods: Standard PRISMA guidelines were followed. A meta-regression
analysis was performed for cardiovascular mortality in small AAA patients
and a qualitative synthesis of the prevalence of concurrent cardiovascular
diseases.
Results: A total 2323 patients with small AAA were identiﬁed (median
follow-up 5 years). A total of 335 cardiovascular deaths occurred, 37 of
which from AAA-rupture, showing a cardiovascular mortality risk of 3.00%
per year in small AAA patients (R2 ¼ 0.902, p < 0.001). The prevalence of
ischaemic heart disease (44.9%), myocardial infarction (26.8%), heart fail-
ure (4.4%) and cerebrovascular disease (14.0%) were high in this patient
group.
Discussion: There is high cardiovascular risk in patients with small AAA,
yet manymay not be taking advantage of optimal cardiovascular risk factor
modiﬁcation. The diagnosis of a small AAA should be seen as a red-ﬂag
sign, triggering lifestyle change and pharmaco-vigilance against cardio-
vascular risk factors.
0726: PATTERNS OF DISEASE PERSISTENCE AND RECURRENCE IN RE-
OPERATIVE PARATHYROIDECTOMY
J.L. Allen 1,*, C. McIntyre 2, V. Constantinides 2, J. Jackson 1, N. Tolley 2, F.
Palazzo 2. 1 Imperial College London, UK; 2Hammersmith Hospital, UK
Aim: Parathyroidectomy is the deﬁnitive cure for primary hyperparathy-
roidism. Re-operative parathyroidectomy is required when the ﬁrst oper-
ation has been unsuccessful, however, re-operative surgery has a higher
complication rate and a higher rate of failure to cure. Our study looked at
our departmental experience of re-operative parathyroidectomy.
Methods: Using an internal database we identiﬁed all patients who had
undergone re-operative parathyroidectomy between 2006 and 2014. We
reviewed results from the pre-operative work up, the operative note, and
the post-operative biochemistry and histology for the initial and re-
operative procedure.
Results: During this time period over 700 parathyroidectomies were
performed. Of these, we identiﬁed 46 re-operative patients for whom we
had the relevant data to include them in the study. A large proportion ofpatients had negative, equivocal or discordant conventional imaging and
therefore went on to have more invasive localisation studies. Most
abnormal parathyroid glands were found in eutopic locations. Of the
ectopic glands, the most common locations were: intra-thyroidal, intra-
thymic, and mediastinal. 10 patients were found to have multiple ade-
nomas and 4 patients had supernumerary parathyroid glands. 28% of the
patients had concurrent thyroid disease.
Conclusion: This study has identiﬁed patterns of disease persistence and
recurrence in patients who have undergone re-operative para-
thyroidectomy.
0911: EXPRESSION PATTERNS OF HUMAN EPIDERMAL GROWTH
FACTOR RECEPTOR PROTEINS IN EARLY GASTRIC CANCER
A. Mohamed 1,*, M. Gandy 1, A. Butt 1, V. Sehgal 1, I. Puccio 1, R. Hamoudi 1, R.
Haidry 1, M. Novelli 1, M. Banks 1, L. Lovat 1, M. Rodriguez-
Justo 1. 1University College London, UK
Aim: The human epidermal growth factor receptor (HER) molecules are
therapeutic targets in epithelial derived cancers. This study investigated
their co-expression in early gastric neoplasia.
Methods: Specimens from 22 suspected early gastric cancer patients were
selected. Tissues were immunostained for EGFR, HER2, HER3 and HER4
overexpression on the Bond immunostainer. EGFR and HER2 were evalu-
ated by interacellular (ICD) and extracellular binding (ECD) antibodies.
Interpretation was performed as per clinical HER2 and EGFR scoring
criteria.
Results: ICD EGFR overexpression was seen in 9% (2/22) of samples but
no overexpression against the EGFR ECD epitope. 13.6% (3/22) showed
ECD HER2 overexpression and 9% (2 of 22) showed overexpression
against the HER2 ECD epitope (3/3 with gene ampliﬁcation). 50% (1 of 2)
of overexpressing showed co-expression of EGFR and HER2. The co-
expressed case showed signiﬁcant disease progression. The pattern of
distribution was heterogeneous in all EGFR cases but uniform in all of
the HER2 cases. HER3 and HER4 overexpression was not seen in any
cases.
Conclusion: This pilot study suggests a relationship between EGFR and
HER2. Interestingly, HER3 and HER4 lacked correlatation with either of
these in contrast to reported relationships. The prognostic utility EGFR and
HER2 co-expression to predict an aggressive early gastric cancer pheno-
type warrants further investigation.
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PROPERTIES OF POLYHEDRAL OLIGOMERIC SILSESQUIOXANE
POLY(CARBONATE-UREA) URETHANE (POSS-PCU) FOR NASAL
RECONSTRUCTION
A. Abdul-Hamid*. University College London, UK
Aim: An unmet need exists for the development of tissue-engineered
materials for biomedical applications, particularly in the ﬁeld of nasal
reconstruction. This study aims to alter the surface properties of poly-
hedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-
PCU), using plasma surface modiﬁcation.
Methods: The surface of porous POSS-PCU was modiﬁed using the plasma
surface modiﬁcation (PSM) technique with ammonia (NH3) and carbon
dioxide (CO2) gases. Surfaces were analysed by comparing the water
contact angle and using attenuated total reﬂectanceeFourier transform
infrared (ATReFTIR) spectroscopy.
Results: Both NH3 and CO2 gases using PSM signiﬁcantly changed the
surface characteristic of POSS-PCU from hydrophobic to hydrophilic
(p < 0.05), with NH3 making the surface more hydrophilic than CO2
(control: 83 CO2: 61 NH3: 6). Comparison of ATReFTIR spectra samples
post PSM demonstrated no changes in material characteristics compared
to controls.
Conclusion: This study demonstrated the ability of PSM to alter the surface
of POSS-PCU for desirable characteristics. By achieving the desired surface
